cloudfront
  • info@reportsandmarkets.com
  • +44-020-3286-9338 (UK) | +1-214-736-7666 (US) | +1-740-994-0111 (US)
  • Sign In
  • Register

Report Detail



Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Stakeholders
2. Research & Forecasting
2.1. Research Methodology
2.1.1. Research Instruments
2.1.1.1. Secondary Instrument
2.1.1.2. Primary Instrument
2.1.2. Research Approaches
2.1.2.1. Bottom-up Approach
2.1.2.2. Top-down Approach
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.1.5. Vendor Inclusion Criteria
2.2. Forecasting Methodology
2.2.1. Methodology for Market Estimation & Forecasting
2.2.2. Significance and Importance of the Market Estimation & Forecasting
3. Executive Summary
3.1. Market Snapshot
3.2. Market Dynamics
3.3. Competitive Analysis
4. Premium Insight
4.1. Market Connectivity
4.2. Market Data Feed
4.3. Market Dynamics
4.3.1. Drivers
4.3.1.1. Geriatric population and prevalence of chronic and infectious diseases in Americas
4.3.1.2. Growing awareness on self-testing and personalized medicine
4.3.1.3. Increasing adoption automated instruments and equipment in laboratories
4.3.1.4. Increasing deployment of Point-of-Care testing facilities
4.3.2. Restraints
4.3.2.1. Unfavourable reimbursement
4.3.3. Opportunities
4.3.3.1. Development of condition-specific markers and tests
4.3.3.2. Attractive companion diagnostics
4.3.3.3. Growth opportunities in emerging countries
4.3.4. Challenges
4.3.4.1. Changing regulatory landscape
4.3.4.2. Operational limitations faced in conducting diagnostic tests
4.4. Porter’s Five Forces Analysis
4.4.1. Threat of New Entrants
4.4.2. Threat of Substitutes
4.4.3. Bargaining Power of Customers
4.4.4. Bargaining Power of Suppliers
4.4.5. Industry Rivalry
5. Industry Trends
5.1. Microfluidics-Based POC and LOC Diagnostic Devices for Laboratory Testing
5.2. Reagent Rental Agreements
5.3. Regulatory Framework
6. Global In-Vitro Diagnostics Market, by Component
6.1. Data Management Software
6.1.1. Overview
6.1.2. Market Sizing & Forecasting
6.2. Instruments
6.2.1. Overview
6.2.2. Market Sizing & Forecasting
6.3. Reagents & Kits
6.3.1. Overview
6.3.2. Market Sizing & Forecasting
6.4. Services
6.4.1. Overview
6.4.2. Market Sizing & Forecasting
7. Global In-Vitro Diagnostics Market, by Technology
7.1. Clinical Chemistry
7.1.1. Overview
7.1.2. Market Sizing & Forecasting
7.1.3. Basic Metabolic Panel
7.1.4. Electrolyte Panel
7.1.5. Lipid Profile
7.1.6. Liver Panel
7.1.7. Renal Profile
7.1.8. Specialty Chemical Tests
7.1.9. Thyroid Function Panel
7.2. Coagulation & Hemostasis
7.2.1. Overview
7.2.2. Market Sizing & Forecasting
7.3. Hematology
7.3.1. Overview
7.3.2. Market Sizing & Forecasting
7.4. Immunochemistry
7.4.1. Overview
7.4.2. Market Sizing & Forecasting
7.4.3. Enzyme-Linked Immunosorbent Assay
7.4.3.1. Chemiluminescence Immunoassays
7.4.3.2. Colorimetric Immunoassays
7.4.3.3. Fluorescence Immunoassays
7.4.4. Enzyme-Linked Immunospot Assays
7.4.5. Radioimmunoassay
7.4.6. Rapid Test
7.4.7. Western Blotting
7.5. Microbiology
7.5.1. Overview
7.5.2. Market Sizing & Forecasting
7.6. Molecular Diagnostics
7.6.1. Overview
7.6.2. Market Sizing & Forecasting
7.6.3. DNA Sequencing & Next-Generation Sequencing
7.6.4. Hybridization
7.6.5. Isothermal Nucleic Acid Amplification Technology
7.6.6. Microarray
7.6.7. Polymerase Chain Reaction
7.7. Urinalysis
7.7.1. Overview
7.7.2. Market Sizing & Forecasting
8. Global In-Vitro Diagnostics Market, by End User
8.1. Hospitals & Care Providers
8.1.1. Overview
8.1.2. Market Sizing & Forecasting
8.2. Laboratories
8.2.1. Overview
8.2.2. Market Sizing & Forecasting
8.3. Patient Self-Testing
8.3.1. Overview
8.3.2. Market Sizing & Forecasting
9. Global In-Vitro Diagnostics Market, by Application
9.1. Autoimmune Diseases
9.1.1. Overview
9.1.2. Market Sizing & Forecasting
9.2. Cardiology
9.2.1. Overview
9.2.2. Market Sizing & Forecasting
9.3. Diabetes
9.3.1. Overview
9.3.2. Market Sizing & Forecasting
9.4. Drug Testing
9.4.1. Overview
9.4.2. Market Sizing & Forecasting
9.5. HIV/Aids
9.5.1. Overview
9.5.2. Market Sizing & Forecasting
9.6. Infectious Diseases
9.6.1. Overview
9.6.2. Market Sizing & Forecasting
9.7. Nephrology
9.7.1. Overview
9.7.2. Market Sizing & Forecasting
9.8. Oncology
9.8.1. Overview
9.8.2. Market Sizing & Forecasting
10. Global In-Vitro Diagnostics Market, by Geography
10.1. Americas
10.1.1. Overview
10.1.2. Market Sizing & Forecasting
10.1.3. United States
10.2. Europe, Middle East & Africa
10.2.1. Overview
10.2.2. Market Sizing & Forecasting
10.2.3. United Kingdom
10.2.4. Germany
10.2.5. Saudi Arabia
10.3. Asia-Pacific
10.3.1. Overview
10.3.2. Market Sizing & Forecasting
10.3.3. China
10.3.4. Japan
10.3.5. India
11. 360iResearch FPNV Positioning Matrix
11.1. 360iResearch Scores
11.1.1. Forefront
11.1.2. Pathfinders
11.1.3. Niche
11.1.4. Vital
11.2. Business Strategy
11.3. Product Satisfaction
12. Competitive News Feed Analysis
13. Company Usability Profiles
13.1. Abbott Laboratories, Inc.
13.1.1. Business Overview
13.1.2. Business Strategy
13.1.3. Business SWOT Analysis
13.2. Agilent Technologies
13.2.1. Business Overview
13.2.2. Business Strategy
13.2.3. Business SWOT Analysis
13.3. Arkray, Inc.
13.3.1. Business Overview
13.3.2. Business Strategy
13.3.3. Business SWOT Analysis
13.4. Becton, Dickinson and Company
13.4.1. Business Overview
13.4.2. Business Strategy
13.4.3. Business SWOT Analysis
13.5. Bio-Rad Laboratories, Inc.
13.5.1. Business Overview
13.5.2. Business Strategy
13.5.3. Business SWOT Analysis
13.6. Biomérieux Sa
13.6.1. Business Overview
13.6.2. Business Strategy
13.6.3. Business SWOT Analysis
13.7. Danaher Corporation
13.7.1. Business Overview
13.7.2. Business Strategy
13.7.3. Business SWOT Analysis
13.8. Diasorin
13.8.1. Business Overview
13.8.2. Business Strategy
13.8.3. Business SWOT Analysis
13.9. Johnson & Johnson
13.9.1. Business Overview
13.9.2. Business Strategy
13.9.3. Business SWOT Analysis
13.10. Ortho Clinical Diagnostics
13.10.1. Business Overview
13.10.2. Business Strategy
13.10.3. Business SWOT Analysis
13.11. Qiagen
13.11.1. Business Overview
13.11.2. Business Strategy
13.11.3. Business SWOT Analysis
13.12. Roche Diagnostics
13.12.1. Business Overview
13.12.2. Business Strategy
13.12.3. Business SWOT Analysis
13.13. Siemens AG
13.13.1. Business Overview
13.13.2. Business Strategy
13.13.3. Business SWOT Analysis
13.14. Sysmex Corporation
13.14.1. Business Overview
13.14.2. Business Strategy
13.14.3. Business SWOT Analysis
13.15. Thermo Fisher Scientific
13.15.1. Business Overview
13.15.2. Business Strategy
13.15.3. Business SWOT Analysis
14. Appendix
14.1. Top Reports
14.2. Author Details

LIST OF TABLES (65 TABLES)

TABLE 1. GLOBAL IN-VITRO DIAGNOSTICS MARKET RANKING, BY KEY PLAYER, 2017
TABLE 2. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, 2016 - 2024 (USD BILLION)
TABLE 3. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 4. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2016 - 2024 (USD BILLION)
TABLE 5. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2016 - 2024 (USD BILLION)
TABLE 6. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2016 - 2024 (USD BILLION)
TABLE 7. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2016 - 2024 (USD BILLION)
TABLE 8. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 9. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 10. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 11. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 12. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 13. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY COAGULATION & HEMOSTASIS, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 14. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 15. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY IMMUNOCHEMISTRY, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 16. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGY, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 17. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 18. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY URINALYSIS, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 19. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 20. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY LABORATORIES, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 21. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT SELF-TESTING, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 22. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 23. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY CARDIOLOGY, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 24. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DIABETES, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 25. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DRUG TESTING, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 26. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HIV/AIDS, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 27. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 28. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY NEPHROLOGY, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 29. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)
TABLE 30. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, 2016 - 2024 (USD BILLION)
TABLE 31. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2016 - 2024 (USD BILLION)
TABLE 32. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2016 - 2024 (USD BILLION)
TABLE 33. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2016 - 2024 (USD BILLION)
TABLE 34. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2016 - 2024 (USD BILLION)
TABLE 35. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, 2016 - 2024 (USD BILLION)
TABLE 36. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2016 - 2024 (USD BILLION)
TABLE 37. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2016 - 2024 (USD BILLION)
TABLE 38. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2016 - 2024 (USD BILLION)
TABLE 39. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2016 - 2024 (USD BILLION)
TABLE 40. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, 2016 - 2024 (USD BILLION)
TABLE 41. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2016 - 2024 (USD BILLION)
TABLE 42. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2016 - 2024 (USD BILLION)
TABLE 43. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2016 - 2024 (USD BILLION)
TABLE 44. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2016 - 2024 (USD BILLION)
TABLE 45. 360IRESEARCH SCORES FOR FOREFRONT IN IN-VITRO DIAGNOSTICS MARKET
TABLE 46. 360IRESEARCH SCORES FOR PATHFINDERS IN IN-VITRO DIAGNOSTICS MARKET
TABLE 47. 360IRESEARCH SCORES FOR NICHE IN IN-VITRO DIAGNOSTICS MARKET
TABLE 48. 360IRESEARCH SCORES FOR VITAL IN IN-VITRO DIAGNOSTICS MARKET
TABLE 49. 360IRESEARCH FPNV POSITIONING MATRIX BUSINESS STRATEGY FOR IN-VITRO DIAGNOSTICS MARKET
TABLE 50. 360IRESEARCH FPNV POSITIONING MATRIX PRODUCT SATISFACTION FOR IN-VITRO DIAGNOSTICS MARKET
TABLE 51. COMPETITIVE NEWS FEED ANALYSIS FOR ABBOTT LABORATORIES, INC. IN IN-VITRO DIAGNOSTICS MARKET
TABLE 52. COMPETITIVE NEWS FEED ANALYSIS FOR AGILENT TECHNOLOGIES IN IN-VITRO DIAGNOSTICS MARKET
TABLE 53. COMPETITIVE NEWS FEED ANALYSIS FOR ARKRAY, INC. IN IN-VITRO DIAGNOSTICS MARKET
TABLE 54. COMPETITIVE NEWS FEED ANALYSIS FOR BECTON, DICKINSON AND COMPANY IN IN-VITRO DIAGNOSTICS MARKET
TABLE 55. COMPETITIVE NEWS FEED ANALYSIS FOR BIO-RAD LABORATORIES, INC. IN IN-VITRO DIAGNOSTICS MARKET
TABLE 56. COMPETITIVE NEWS FEED ANALYSIS FOR BIOMéRIEUX SA IN IN-VITRO DIAGNOSTICS MARKET
TABLE 57. COMPETITIVE NEWS FEED ANALYSIS FOR DANAHER CORPORATION IN IN-VITRO DIAGNOSTICS MARKET
TABLE 58. COMPETITIVE NEWS FEED ANALYSIS FOR DIASORIN IN IN-VITRO DIAGNOSTICS MARKET
TABLE 59. COMPETITIVE NEWS FEED ANALYSIS FOR JOHNSON & JOHNSON IN IN-VITRO DIAGNOSTICS MARKET
TABLE 60. COMPETITIVE NEWS FEED ANALYSIS FOR ORTHO CLINICAL DIAGNOSTICS IN IN-VITRO DIAGNOSTICS MARKET
TABLE 61. COMPETITIVE NEWS FEED ANALYSIS FOR QIAGEN IN IN-VITRO DIAGNOSTICS MARKET
TABLE 62. COMPETITIVE NEWS FEED ANALYSIS FOR ROCHE DIAGNOSTICS IN IN-VITRO DIAGNOSTICS MARKET
TABLE 63. COMPETITIVE NEWS FEED ANALYSIS FOR SIEMENS AG IN IN-VITRO DIAGNOSTICS MARKET
TABLE 64. COMPETITIVE NEWS FEED ANALYSIS FOR SYSMEX CORPORATION IN IN-VITRO DIAGNOSTICS MARKET
TABLE 65. COMPETITIVE NEWS FEED ANALYSIS FOR THERMO FISHER SCIENTIFIC IN IN-VITRO DIAGNOSTICS MARKET

LIST OF FIGURES (85 TABLES)

FIGURE 1. GLOBAL IN-VITRO DIAGNOSTICS MARKET: YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL IN-VITRO DIAGNOSTICS MARKET: KEY RESEARCH METHODOLOGY
FIGURE 3. GLOBAL IN-VITRO DIAGNOSTICS MARKET: KEY RESEARCH INSTRUMENTS
FIGURE 4. GLOBAL IN-VITRO DIAGNOSTICS MARKET: KEY SECONDARY INSTRUMENT SOURCES
FIGURE 5. GLOBAL IN-VITRO DIAGNOSTICS MARKET: KEY POTENTIAL RESPONDENTS
FIGURE 6. GLOBAL IN-VITRO DIAGNOSTICS MARKET: KEY BREAKDOWN OF PRIMARY INSTRUMENT
FIGURE 7. GLOBAL IN-VITRO DIAGNOSTICS MARKET: KEY RESEARCH APPROACHES
FIGURE 8. GLOBAL IN-VITRO DIAGNOSTICS MARKET: KEY DATA TRIANGULATION
FIGURE 9. GLOBAL IN-VITRO DIAGNOSTICS MARKET: KEY RESEARCH ASSUMPTIONS
FIGURE 10. IN-VITRO DIAGNOSTICS MARKET: KEY MARKET CONNECTIVITY
FIGURE 11. GLOBAL IN-VITRO DIAGNOSTICS MARKET SHARE, BY GEOGRAPHY, 2017 (%)
FIGURE 12. GLOBAL IN-VITRO DIAGNOSTICS MARKET SHARE, BY COMPONENT, 2017 (%)
FIGURE 13. GLOBAL IN-VITRO DIAGNOSTICS MARKET SHARE, BY TECHNOLOGY, 2017 (%)
FIGURE 14. GLOBAL IN-VITRO DIAGNOSTICS MARKET SHARE, BY END USER, 2017 (%)
FIGURE 15. GLOBAL IN-VITRO DIAGNOSTICS MARKET SHARE, BY APPLICATION, 2017 (%)
FIGURE 16. GLOBAL IN-VITRO DIAGNOSTICS MARKET: KEY MARKET DYNAMICS
FIGURE 17. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, 2016 - 2024 (USD BILLION)
FIGURE 18. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2017 (USD BILLION)
FIGURE 19. GLOBAL IN-VITRO DIAGNOSTICS MARKET OPPORTUNITY ANALYSIS, BY GEOGRAPHY, 2024 (USD BILLION)
FIGURE 20. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2017 (USD BILLION)
FIGURE 21. GLOBAL IN-VITRO DIAGNOSTICS MARKET OPPORTUNITY ANALYSIS, BY COMPONENT, 2024 (USD BILLION)
FIGURE 22. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017 (USD BILLION)
FIGURE 23. GLOBAL IN-VITRO DIAGNOSTICS MARKET OPPORTUNITY ANALYSIS, BY TECHNOLOGY, 2024 (USD BILLION)
FIGURE 24. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2017 (USD BILLION)
FIGURE 25. GLOBAL IN-VITRO DIAGNOSTICS MARKET OPPORTUNITY ANALYSIS, BY END USER, 2024 (USD BILLION)
FIGURE 26. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017 (USD BILLION)
FIGURE 27. GLOBAL IN-VITRO DIAGNOSTICS MARKET OPPORTUNITY ANALYSIS, BY APPLICATION, 2024 (USD BILLION)
FIGURE 28. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY GEOGRAPHY, 2017 (USD BILLION)
FIGURE 29. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 30. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY GEOGRAPHY, 2017 (USD BILLION)
FIGURE 31. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 32. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, BY GEOGRAPHY, 2017 (USD BILLION)
FIGURE 33. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 34. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, BY GEOGRAPHY, 2017 (USD BILLION)
FIGURE 35. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 36. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY GEOGRAPHY, 2017 (USD BILLION)
FIGURE 37. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 38. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY COAGULATION & HEMOSTASIS, BY GEOGRAPHY, 2017 (USD BILLION)
FIGURE 39. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY COAGULATION & HEMOSTASIS, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 40. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY GEOGRAPHY, 2017 (USD BILLION)
FIGURE 41. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 42. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY IMMUNOCHEMISTRY, BY GEOGRAPHY, 2017 (USD BILLION)
FIGURE 43. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY IMMUNOCHEMISTRY, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 44. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGY, BY GEOGRAPHY, 2017 (USD BILLION)
FIGURE 45. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGY, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 46. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GEOGRAPHY, 2017 (USD BILLION)
FIGURE 47. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 48. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY URINALYSIS, BY GEOGRAPHY, 2017 (USD BILLION)
FIGURE 49. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY URINALYSIS, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 50. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY GEOGRAPHY, 2017 (USD BILLION)
FIGURE 51. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 52. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY LABORATORIES, BY GEOGRAPHY, 2017 (USD BILLION)
FIGURE 53. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY LABORATORIES, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 54. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT SELF-TESTING, BY GEOGRAPHY, 2017 (USD BILLION)
FIGURE 55. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT SELF-TESTING, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 56. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY GEOGRAPHY, 2017 (USD BILLION)
FIGURE 57. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 58. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY CARDIOLOGY, BY GEOGRAPHY, 2017 (USD BILLION)
FIGURE 59. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY CARDIOLOGY, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 60. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DIABETES, BY GEOGRAPHY, 2017 (USD BILLION)
FIGURE 61. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DIABETES, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 62. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DRUG TESTING, BY GEOGRAPHY, 2017 (USD BILLION)
FIGURE 63. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DRUG TESTING, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 64. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HIV/AIDS, BY GEOGRAPHY, 2017 (USD BILLION)
FIGURE 65. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HIV/AIDS, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 66. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY GEOGRAPHY, 2017 (USD BILLION)
FIGURE 67. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 68. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY NEPHROLOGY, BY GEOGRAPHY, 2017 (USD BILLION)
FIGURE 69. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY NEPHROLOGY, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 70. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2017 (USD BILLION)
FIGURE 71. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 72. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 73. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, 2017 VS 2024 (USD BILLION)
FIGURE 74. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 75. UNITED KINGDOM IN-VITRO DIAGNOSTICS MARKET SIZE, 2017 VS 2024 (USD BILLION)
FIGURE 76. GERMANY IN-VITRO DIAGNOSTICS MARKET SIZE, 2017 VS 2024 (USD BILLION)
FIGURE 77. SAUDI ARABIA IN-VITRO DIAGNOSTICS MARKET SIZE, 2017 VS 2024 (USD BILLION)
FIGURE 78. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)
FIGURE 79. CHINA IN-VITRO DIAGNOSTICS MARKET SIZE, 2017 VS 2024 (USD BILLION)
FIGURE 80. JAPAN IN-VITRO DIAGNOSTICS MARKET SIZE, 2017 VS 2024 (USD BILLION)
FIGURE 81. INDIA IN-VITRO DIAGNOSTICS MARKET SIZE, 2017 VS 2024 (USD BILLION)
FIGURE 82. 360IRESEARCH FPNV POSITIONING MATRIX FOR IN-VITRO DIAGNOSTICS MARKET
FIGURE 83. COMPETITIVE NEWS FEED ANALYSIS IN GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY NEWS TYPE
FIGURE 84. COMPETITIVE NEWS FEED ANALYSIS IN GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY COMPANY
FIGURE 85. COMPETITIVE NEWS FEED ANALYSIS IN GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY YEAR

“Geriatric population and prevalence of chronic and infectious diseases in Americas
is one of the factors largely attributing to the growth of in-vitro diagnostics market globally”

The global in-vitro diagnostics market is expected to grow from USD 62.77 billion 2017 to USD 92.62 billion by the end of 2024, at a Compound Annual Growth Rate (CAGR) of 5.71%.

Market Segmentation & Coverage: The report on global in-vitro diagnostics market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the economies and geographies of the potential customer group can help to gain business acumen for better strategic decision making. Our market coverage across different industry verticals reveals the hidden truth about the strategies adopted by the players in different verticals and help the organization to decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.This research report categorizes the global in-vitro diagnostics market to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Component
1. Data Management Software
2. Instruments
3. Reagents & Kits
4. Services

Based on Technology
1. Clinical Chemistry
2. Coagulation & Hemostasis
3. Hematology
4. Immunochemistry
5. Microbiology
6. Molecular Diagnostics
7. Urinalysis

Based on End User
1. Hospitals & Care Providers
2. Laboratories
3. Patient Self-Testing

Based on Application
1. Autoimmune Diseases
2. Cardiology
3. Diabetes
4. Drug Testing
5. HIV/Aids
6. Infectious Diseases
7. Nephrology
8. Oncology

Based on Geography
1. Americas (United States)
2. Europe, Middle East & Africa (United Kingdom, Germany, and Saudi Arabia)
3. Asia-Pacific (China, Japan, and India)

Company Usability Profiles:
The in-vitro diagnostics market research report provides the company usability profiles and analyze the business overview, business product offering, SWOT analysis, and business strategy of the following company:
1. Abbott Laboratories, Inc.
2. Agilent Technologies
3. Arkray, Inc.
4. Becton, Dickinson and Company
5. Bio-Rad Laboratories, Inc.
6. Biomérieux Sa
7. Danaher Corporation
8. Diasorin
9. Johnson & Johnson
10. Ortho Clinical Diagnostics
11. Qiagen
12. Roche Diagnostics
13. Siemens AG
14. Sysmex Corporation
15. Thermo Fisher Scientific

Research Methodology:
Our market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.

Reasons to Buy:
1. To comprehensively understand of the in-vitro diagnostics market with respect to major influencing factor such as drivers, restraints, opportunities and challenges
2. To strategically analyze each vertical and geographic sub-segment in the in-vitro diagnostics market and its individual growth and its impact towards the growth of overall market
3. To position selected vendors in 360iResearch FPNV Positioning Matrix for the in-vitro diagnostics market to uncover a competitive landscape based on business strategy and product satisfaction




Summary:
Get latest Market Research Reports on In-Vitro Diagnostics. Industry analysis & Market Report on In-Vitro Diagnostics is a syndicated market report, published as The global in-vitro diagnostics market is expected to grow from USD 62.77 billion 2017 to USD 92.62 billion by the end of 2024, at a CAGR of 5.71%.. It is complete Research Study and Industry Analysis of In-Vitro Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$2,999.00
$3,999.00
$4,999.00
2,013.83
2,685.33
3,356.83
2,759.68
3,679.88
4,600.08
363,298.86
484,438.86
605,578.86
198,873.89
265,187.29
331,500.69
Add To Cart Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report